Double-blind, placebo-controlled Phase II studies of the PAR-1 antagonist E5555 in Japanese patients with acute coronary syndrome(ACS) or high-risk coronary artery disease(CAD)

Bibliographic Information

Title
Double-blind, placebo-controlled Phase II studies of the PAR-1 antagonist E5555 in Japanese patients with acute coronary syndrome(ACS) or high-risk coronary artery disease(CAD)
Author
Goto S, Ogawa H, Takeuchi M, Flather M, Bhatt DL
Published
2010
Resource Type
journal article

Journal

Related Projects

See more

Details 詳細情報について

  • CRID
    1010000782084877446
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top